ZNF224, Krüppel like zinc finger protein, induces cell growth and apoptosis-resistance by down-regulation of p21 and p53 via miR-663a

Oncotarget

Volumn 7, Issue 21, 2016, Pages 31177-31190

  Cho, Jin Gu ^a,b   Park, Seho ^c   Lim, Chae Hyun ^d   Kim, Hong Sook ^b   Song, Seung Yong ^c   Roh, Tae Young ^d   Sung, Jong Hyuk ^e   Suh, Wonhee ^f   Ham, Seok Jin ^d   Lim, Key Hwan ^b   Park, Sang Gyu ^b  

^a CHA University   (South Korea)

^b Ajou University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Pohang University of Science and Technology (POSTECH)   (South Korea)

^e Yonsei University   (South Korea)

^f Chung Ang University   (South Korea)

Author keywords

Apoptosis; MiR 663a; P21; P53; ZNF224

Indexed keywords

DNA; MICRORNA; MICRORNA 663A; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZNF224; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MIRN663 MICRORNA, HUMAN; REPRESSOR PROTEIN; TP53 PROTEIN, HUMAN; ZNF224 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CELL SURVIVAL; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; EMBRYO; HUMAN; HUMAN CELL; HUMAN TISSUE; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA TRANSCRIPTION; BREAST TUMOR; CELL CYCLE; CELL PROLIFERATION; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; MCF-7 CELL LINE; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; GENES, P53; HEK293 CELLS; HUMANS; MCF-7 CELLS; MICRORNAS; REPRESSOR PROTEINS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84971569515     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.8870     Document Type: Article

References (48)

1. Agata Y, Matsuda E, Shimizu A. Two novel Kruppelassociated box-containing zinc-finger proteins, KRAZ1 and KRAZ2, repress transcription through functional interaction with the corepressor KAP-1 (TIF1beta/KRIP-1). J Biol Chem. 1999; 274: 16412-16422.
2. Witzgall R, O'Leary E, Leaf A, Onaldi D, Bonventre JV. The Kruppel-associated box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression. Proc Natl Acad Sci U S A. 1994; 91: 4514-4518.
3. Looman C, Abrink M, Mark C, Hellman L. KRAB zinc finger proteins: an analysis of the molecular mechanisms governing their increase in numbers and complexity during evolution. Mol Biol Evol. 2002; 19: 2118-2130.
4. Urrutia R. KRAB-containing zinc-finger repressor proteins. Genome Biol. 2003; 4: 231.
5. Lupo A, Cesaro E, Montano G, Zurlo D, Izzo P, Costanzo P. KRAB-Zinc Finger Proteins: A Repressor Family Displaying Multiple Biological Functions. Curr Genomics. 2013; 14: 268-278.
6. Friedman JR, Fredericks WJ, Jensen DE, Speicher DW, Huang XP, Neilson EG, Rauscher FJ, 3rd. KAP-1, a novel corepressor for the highly conserved KRAB repression domain. Genes Dev. 1996; 10: 2067-2078.
7. Quenneville S, Turelli P, Bojkowska K, Raclot C, Offner S, Kapopoulou A, Trono D. The KRAB-ZFP/KAP1 system contributes to the early embryonic establishment of site-specific DNA methylation patterns maintained during development. Cell Rep. 2012; 2: 766-773.
8. Krebs CJ, Schultz DC, Robins DM. The KRAB zinc finger protein RSL1 regulates sex-and tissue-specific promoter methylation and dynamic hormone-responsive chromatin configuration. Mol Cell Biol. 2012; 32: 3732-3742.
9. Matsuda E, Agata Y, Sugai M, Katakai T, Gonda H, Shimizu A. Targeting of Kruppel-associated box-containing zinc finger proteins to centromeric heterochromatin. Implication for the gene silencing mechanisms. J Biol Chem. 2001; 276: 14222-14229.
10. Medugno L, Costanzo P, Lupo A, Monti M, Florio F, Pucci P, Izzo P. A novel zinc finger transcriptional repressor, ZNF224, interacts with the negative regulatory element (AldA-NRE) and inhibits gene expression. FEBS Lett. 2003; 534: 93-100.
11. Lupo A, Cesaro E, Montano G, Izzo P, Costanzo P. ZNF224: Structure and role of a multifunctional KRABZFP protein. Int J Biochem Cell Biol. 2011; 43: 470-473.
12. Medugno L, Florio F, Cesaro E, Grosso M, Lupo A, Izzo P, Costanzo P. Differential expression and cellular localization of ZNF224 and ZNF255, two isoforms of the Kruppel-like zinc-finger protein family. Gene. 2007; 403: 125-131.
13. Florio F, Cesaro E, Montano G, Izzo P, Miles C, Costanzo P. Biochemical and functional interaction between ZNF224 and ZNF255, two members of the Kruppel-like zinc-finger protein family and WT1 protein isoforms. Hum Mol Genet. 2010; 19: 3544-3556.
14. Medugno L, Florio F, De Cegli R, Grosso M, Lupo A, Costanzo P, Izzo P. The Kruppel-like zinc-finger protein ZNF224 represses aldolase A gene transcription by interacting with the KAP-1 co-repressor protein. Gene. 2005; 359: 35-43.
15. di Caprio R, Ciano M, Montano G, Costanzo P, Cesaro E. KAP1 is a Novel Substrate for the Arginine Methyltransferase PRMT5. Biology (Basel). 2015; 4: 41-49.
16. Cesaro E, De Cegli R, Medugno L, Florio F, Grosso M, Lupo A, Izzo P, Costanzo P. The Kruppel-like zinc finger protein ZNF224 recruits the arginine methyltransferase PRMT5 on the transcriptional repressor complex of the aldolase A gene. J Biol Chem. 2009; 284: 32321-32330.
17. Iacobazzi V, Infantino V, Convertini P, Vozza A, Agrimi G, Palmieri F. Transcription of the mitochondrial citrate carrier gene: identification of a silencer and its binding protein ZNF224. Biochem Biophys Res Commun. 2009; 386: 186-191.
18. Harada Y, Kanehira M, Fujisawa Y, Takata R, Shuin T, Miki T, Fujioka T, Nakamura Y, Katagiri T. Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells. Cancer Res. 2010; 70: 5829-5839.
19. Di Micco R, Sulli G, Dobreva M, Liontos M, Botrugno OA, Gargiulo G, dal Zuffo R, Matti V, d'Ario G, Montani E, Mercurio C, Hahn WC, Gorgoulis V, et al. Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer. Nat Cell Biol. 2011; 13: 292-302.
20. Jiao L, Deng Z, Xu C, Yu Y, Li Y, Yang C, Chen J, Liu Z, Huang G, Li LC, Sun Y. miR-663 induces castrationresistant prostate cancer transformation and predicts clinical recurrence. J Cell Physiol. 2014; 229: 834-844.
21. Liu ZY, Zhang GL, Wang MM, Xiong YN, Cui HQ. MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation. Asian Pac J Cancer Prev. 2011; 12: 2819-2823.
22. Hu H, Li S, Cui X, Lv X, Jiao Y, Yu F, Yao H, Song E, Chen Y, Wang M, Lin L. The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2). J Biol Chem. 2013; 288: 10973-10985.
23. Yi C, Wang Q, Wang L, Huang Y, Li L, Liu L, Zhou X, Xie G, Kang T, Wang H, Zeng M, Ma J, Zeng Y, et al. MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene. 2012; 31: 4421-4433.
24. Pan J, Hu H, Zhou Z, Sun L, Peng L, Yu L, Sun L, Liu J, Yang Z, Ran Y. Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells. Oncol Rep. 2010; 24: 105-112.
25. Yan-Fang T, Jian N, Jun L, Na W, Pei-Fang X, Wen-Li Z, Dong W, Li P, Jian W, Xing F, Jian P. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML). BMC Med Genet. 2013; 14: 74.
26. Yang Y, Wang LL, Wang HX, Guo ZK, Gao XF, Cen J, Li YH, Dou LP, Yu L. The epigenetically-regulated miR-663 targets H-ras in K-562 cells. FEBS J. 2013; 280: 5109-5117.
27. Shi Y, Chen C, Zhang X, Liu Q, Xu JL, Zhang HR, Yao XH, Jiang T, He ZC, Ren Y, Cui W, Xu C, Liu L, et al. Primate-specific miR-663 functions as a tumor suppressor by targeting PIK3CD and predicts the prognosis of human glioblastoma. Clin Cancer Res. 2014; 20: 1803-1813.
28. Zhang Y, Zhou X, Xu X, Zhang M, Wang X, Bai X, Li H, Kan L, Zhou Y, Niu H, He P. Waltonitone induces apoptosis through mir-663-induced Bcl-2 downregulation in non-small cell lung cancer. Tumour Biol. 2015; 36: 871-876.
29. Zang W, Wang Y, Wang T, Du Y, Chen X, Li M, Zhao G. miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer. Mol Cancer. 2015; 14: 37.
30. Shi Y, Chen C, Yu SZ, Liu Q, Rao J, Zhang HR, Xiao HL, Fu TW, Long H, He ZC, Zhou K, Yao XH, Cui YH, et al. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma. Clin Cancer Res. 2015; 21: 4004-4013.
31. Bi C, Chung TH, Huang G, Zhou J, Yan J, Ahmann GJ, Fonseca R, Chng WJ. Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma. Oncotarget. 2015.
32. Lee SH, Kang YJ, Kim DH, Sung B, Kang JA, Chun P, Yoon JH, Moon HR, Kim HS, Chung HY, Kim ND. A novel oxiranylchromenone derivative, MHY336, induces apoptosis and cell cycle arrest via a p53-and p21-dependent pathway in HCT116 human colon cancer cells. Int J Oncol. 2014; 44: 943-949.
33. Montano G, Cesaro E, Fattore L, Vidovic K, Palladino C, Crescitelli R, Izzo P, Turco MC, Costanzo P. Role of WT1-ZNF224 interaction in the expression of apoptosisregulating genes. Hum Mol Genet. 2013; 22: 1771-1782.
34. Brayer KJ, Kulshreshtha S, Segal DJ. The protein-binding potential of C2H2 zinc finger domains. Cell Biochem Biophys. 2008; 51: 9-19.
35. Najafabadi HS, Mnaimneh S, Schmitges FW, Garton M, Lam KN, Yang A, Albu M, Weirauch MT, Radovani E, Kim PM, Greenblatt J, Frey BJ, Hughes TR. C2H2 zinc finger proteins greatly expand the human regulatory lexicon. Nat Biotechnol. 2015; 33: 555-562.
36. Peng H, Zheng L, Lee WH, Rux JJ, Rauscher FJ, 3rd. A common DNA-binding site for SZF1 and the BRCA1-associated zinc finger protein, ZBRK1. Cancer Res. 2002; 62: 3773-3781.
37. Frietze S, Lan X, Jin VX, Farnham PJ. Genomic targets of the KRAB and SCAN domain-containing zinc finger protein 263. J Biol Chem. 2010; 285: 1393-1403.
38. Li Q, Han Y, Wang C, Shan S, Wang Y, Zhang J, Ren T. MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer. Cancer Cell Int. 2015; 15: 84.
39. Wang X, Zhang Y, Fu Y, Zhang J, Yin L, Pu Y, Liang G. MicroRNA-125b may function as an oncogene in lung cancer cells. Mol Med Rep. 2015; 11: 3880-3887.
40. Ma S, Tang KH, Chan YP, Lee TK, Kwan PS, Castilho A, Ng I, Man K, Wong N, To KF, Zheng BJ, Lai PB, Lo CM, et al. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell. 2010; 7: 694-707.
41. Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, Chaix A, Fazli L, Motoo Y, et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci U S A. 2007; 104: 16170-16175.
42. Yun J, Lee WH. Degradation of transcription repressor ZBRK1 through the ubiquitin-proteasome pathway relieves repression of Gadd45a upon DNA damage. Mol Cell Biol. 2003; 23: 7305-7314.
43. Xiao TZ, Suh Y, Longley BJ. MAGE proteins regulate KRAB zinc finger transcription factors and KAP1 E3 ligase activity. Arch Biochem Biophys. 2014; 563: 136-144.
44. Doyle JM, Gao J, Wang J, Yang M, Potts PR. MAGERING protein complexes comprise a family of E3 ubiquitin ligases. Mol Cell. 2010; 39: 963-974.
45. Addison JB, Koontz C, Fugett JH, Creighton CJ, Chen D, Farrugia MK, Padon RR, Voronkova MA, McLaughlin SL, Livengood RH, Lin CC, Ruppert JM, Pugacheva EN, et al. KAP1 promotes proliferation and metastatic progression of breast cancer cells. Cancer Res. 2015; 75: 344-355.
46. Jo J, Song H, Park SG, Lee SH, Ko JJ, Park JH, Jeong J, Cheon YP, Lee DR. Regulation of differentiation potential of human mesenchymal stem cells by intracytoplasmic delivery of coactivator-associated arginine methyltransferase 1 protein using cell-penetrating peptide. Stem Cells. 2012; 30: 1703-1713.
47. Choe MK, Hong CP, Park J, Seo SH, Roh TY. Functional elements demarcated by histone modifications in breast cancer cells. Biochem Biophys Res Commun. 2012; 418: 475-482.
48. Yu MA, Cho JG, Kim KI, Jo YJ, Sung JH, Yang HB, Park SG. Generation of med28 specific monoclonal antibodies. Monoclon Antib Immunodiagn Immunother. 2015; 34: 30-35.